BackBetter Therapeutics Overview

Better Therapeutics Total Liabilities

Latest total liabilities for MCAD: $21M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$20.66M
↓ 1.48% YoYΔ $-310000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Better Therapeutics Total Liabilities History

Loading

Better Therapeutics vs. peers: Total Liabilities Comparison

Loading

Better Therapeutics Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Better Therapeutics (MCAD) FAQ

As of the most recent data (September 2023), MCAD shows a total liabilities of $21M. That compares with $21M in the prior-year period — down 1.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, MCAD's total liabilities is now $21M (was $21M) — a 1.5% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Better Therapeutics is outperforming or lagging.

Tracking MCAD's total liabilities over time shows whether Better Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $21M That compares with $21M in the prior-year period — down 1.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has Better Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $21M) with ownership activity and broader fundamentals.